Gliomas

Cancer Surveys

Volumn 32, Issue , 1998, Pages 37-51

  Collins, V P ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ASTROCYTOMA; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME LOSS; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; DISEASE PROGRESSION; G1 PHASE; GLIOBLASTOMA; GLIOMA; HUMANS; MIDDLE AGED; MUTATION; NEUROGLIA; PRECANCEROUS CONDITIONS; S PHASE;

EID: 0031693880     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Albarosa R, Colombo BM, Roz L et al (1996) Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. American Journal of Human Genetics 58 1260-1267
2. Bigner SH, Mark J, Mahaley JMS and Bigner DD (1984) Patterns of the early gross chromosomal changes in malignant human gliomas. Hereditas 101 103-113
3. Bigner SH, Burger PC, Wong AJ et al (1988a) Gene amplification in malignant human gliomas: clinical and histopathologic aspects. Journal of Neuropathology and Experimental Neurology 47 191-205
4. Bigner SH, Mark J, Burger PC et al (1988b) Specific chromosomal abnormalities in malignant human gliomas. Cancer Research 48 405-411
5. Bigner SH, Murk J and Bigner DD (1990) Cytogenetics of human brain tumors. Cancer, Genetics and Cytogenetics 47 141-154
6. Costollo JF, Berger MS, Huang HS and Cavenee WK (1996) Silencing of pl6/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Research 56 2405-2410
7. Ekstrand AJ, James CD, Cavenee WK et al (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Research 51 2164-2172
8. Ekstrand AJ, Sugawa N, James CD and Collins VP (1992) Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proceedings of the National Academy of Sciences of the USA 89 4309-4313
9. Ekstrand AJ, Longo N, Hamid ML, et al (1994) Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9 2313-2320
10. el-Azouzi M, Chung RY, Farmer GE et al (1989) Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proceedings of the National Academy of Sciences of the USA 86 7186-7190
11. Fueyo J, Gomez-Manzano C, Bruner JM et al (1996) Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas. Oncogene 13 1615-1619
12. Fujimoto M, Fults DW, Thomas GA et al (1989) Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4 210-214
13. Fults D and Pedone C (1993) Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes, Chromosomes and Cancer 7 173-177
14. Fults D, Pedone CA, Thomas GA and White R (1990) Allelotype of human malignant astrocytoma. Cancer Research 50 5784-5789
15. Fults D, Brockmeyer D, Tullous MW, Pedone CA and Cawthon RM (1992) p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression, Cancer Research 52 674-679
16. Gonzalez-Zulueta M, Bender CM, Yang AS et al (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Research 55 4531-4535
17. Herman JG, Merlo A, Mao L et al (1995) Inactivation of the CDKN2/pl6/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research 55 4525-4530
18. Hoang-Xuan K, Merel P, Vega F et al (1995) Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. International journal of Cancer 60 478-481
19. Humphrey PA, Wong AJ, Vogelstein B et al (1990) Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proceedings of the National Academy of Sciences of the USA 87 4207-4211
20. Hunter T and Pines J (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79 573-582
21. Ichimuru K. Schmidt EE, Goike HM and Collins VP (1996) Human glioblastomas with no alterations of the CDKN2A (p16INK4a, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13 1065-1072
22. Ichimura K, Schmidt EE, Miyakawa A, Goike HM and Collins VP (1998) Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes, Chromosomes and Cancer 22 9-15
23. James CD, Carlbom E, Dumanski JP et al (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Research 48 5546-5551
24. James CD, Carlbom E, Nordenskjold M, Collins VP and Cavenee WK (1989) Mitotic recombination of chromosome 17 in astrocytomas. Proceedings of the National Academy of Sciences of the USA 86 2858-2862
25. James CD, He J, Carlbom E et al (1990) Loss of genetic information in central nervous system tumors common to children and young adults. Genes, Chromosomes and Cancer 2 94-102
26. Jenkins RB, Kimmel DW, Moertel CA et al (1989) A cytogenetic study of 53 human gliomas. Cancer Genetics and Cytogenetics 39 253-279
27. Kallioniemi A, Kallioniemi OP, Sudar D et al (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 818-821
28. Karlbom AE, James CD, Boethius J et al (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Human Genetics 92 169-174
29. Karnes PS, Tran TN, Cui MY et al (1992) Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genetics and Cytogenetics 59 12-19
30. Kimmel DW, O'Fallon JR, Scheithauer BW et al (1992) Prognostic value of cytogenetic analysis in human cerebral astrocytomas. Annals of Neurology 31 534-542
31. Kimmelman AC, Ross DA and Liang BC (1996) Loss of heterozygosity of chromosome 10p in human gliomas. Genomics 34 250-254
32. Kleihues P, Burger PC and Scheithauer BW (1993) Histological Typing of Tumors of the Central Nervous System, Springer-Verlag, New York
33. Kraus JA, Bolln C, Wolf HK et al (1994) TP53 alterations and clinical outcome in low grade-astrocytomas. Genes, Chromosomes and Cancer 10 143-149
34. Lang FF, Miller DC, Pisharody S, Koslow M and Newcomb EW (1994) High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Oncogene 9 949-954
35. Li J, Yen C, Liaw D et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 1943-1947
36. Liang BC, Ross DA, Greenberg HS, Meltzer PS and Trent JM (1994) Evidence of allelic imbalance of chromosome 6 in human astrocytomas (erratum Neurology [1994] 44 1190). Neurology 44 533-536
37. Libermann TA, Nusbaum HR, Razon N et al (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313 144-147
38. McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ and Ransohoff J (1992) Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31 636-642 and 642
39. Merlo A, Herman JG, Mao L et al (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine 1 686-692
40. Mohapatra G, Kim DH and Feuerstein BG (1995) Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes, Chromosomen and Cancer 13 86-93
41. Morgan DO (1995) Principles of CDK regulation. Nature 374 131-134
42. Muleris M, Almeida A, Dutrillaux AM et al (1994) Oncogene amplification in human gliomas: a molecular cytogenetic analysis. Oncogene 9 2717-2722
43. Myers MP, Stolarov JP, Eng C et al (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proceedings of the National Academy of Sciences of the USA 94 9052-9057
44. Nishikawa R, Ji XD, Harmon RC et al (1994) A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proceedings of the National Academy of Sciences of the USA 91 7727-7731
45. Ohgaki H, Eibl RH, Schwab M et al (1993) Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Molecular Carcinogenesis 8 74-80
46. Platten M, Giordano MJ, Dirven CM, Gutmann DH and Louis DN (1996) Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas. American Journal of Pathology 149 621-627
47. Ransom DT, Ritland SR, Kimmel DW et al (1992a) Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genen, Chromosomes and Cancer 5 348-356
48. Ransom DT, Ritland SR, Moertel CA et al (1992b) Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes, Chromosomen and Cancer 5 357-374
49. Rasheed BK, Fuller GN, Friedman AH, Bigner DD and Bigner SH (1992) Loss of heterozygosity for 10q loci in human gliomas. Genes, Chromosomes and Cancer 5 75-82
50. Rasheed BK, McLendon RE, Herndon JE et al (1994) Alterations of the TP53 gene in human gliomas. Cancer Research 54 1324-1330
51. Rasheed BK, McLendon RE, Friedman HS et al (1995) Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10 2243-2246
52. Rasheed BKA, Stenzel TT, McLendon RE et al (1997) Pten gene mutations are seen in high- grade but not in low-grade gliomas. Cancer Research 57 4187-4190
53. Reifenberger G, Liu L, Ichimura K, Schmidt EE and Collins VP (1993) Amplification and over- expression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Research 53 2736-2739
54. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS and Collins VP (1994) Amplification of multiple genes from chromosomal region 12ql3-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Research 54 4299-4303
55. Reifenberger G, Reifenberger J, Ichimura K and Collins VP (1995) Amplification at 12ql3-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site. Cancer Research 55 731-734
56. Reifenberger G, Ichimura K, Reifenberger J et al (1996a) Refined mapping of 12ql3-ql5 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Research 56 5141-5145
57. Reifenberger J, Ring GU, Gies U et al (1996b) Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. Journal of Neuropathology and Experimental Neurology 55 822-831
58. Rey JA, Bello MJ, de Campos JM et al (1987) Chromosomal patterns in human malignant astrocytomas. Cancer Genetics and Cytogenetics 29 201-221
59. Scherer HJ (1940) Cerebral astrocytomas and their derivatives. American Journal of Cancer 40 159-198
60. Schmidt EE, Ichimura K, Reifenberger G and Collins VP (1994) CDKN2 (p16VMTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research 54 6321-6324
61. Schmidt EE, Ichimura K, Messerle KR, Goike HM and Collins VP (1997) Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours. British Journal of Cancer 75 2-8
62. Schröck E, Thiel G, Lozanova T et al (1994) Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. American Journal of Pathology 144 1203-1218
63. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79 551-555
64. Sherr CJ and Roberts JM (1995) Inhibitors of mammalian Gl cyclin-dependent kinases. Genes and Development 9 1149-1163
65. Simpson JR, Horton J, Scott C et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. International Journal of Radiation Oncology, Biology, Physics 26 239-244
66. Steck PA, Pershouse MA, Jasser SA et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics 15 356-362
67. Sugawa N, Ekstrand AJ, James CD and Calling VP (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proceedings of the National Academy of Sciences of the USA 87 8602-8606
68. Ueki K, Ono Y, Hensen JW et al (1996) Cdkn2/pl6 or rb alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Research 56 150-153
69. Ullrich A, Coussens L, Hayflick JS et al (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309 418-425
70. von Deimling A, Eibl RH, Ohgaki H et al (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Research 52 2987-2990
71. von Deimling A, Louis DN, Menon AG et al (1993a) Deletions on the long arm of chromosome 17 in pilocytic astrocytoma. Acta Neuropathologica 86 81-85
72. von Deimling A, von Amman K, Schoenfeld D et al (1993b) Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathology 3 19-26
73. von Deimling A, Louis DN and Wiestier OD (1995) Molecular pathways in the formation of gliomas. Glia 15 328-338
74. Wang SI, Puc J, Li J et al (1997) Somatic mutations of pten in glioblastoma multiforme. Cancer Research 57 4183-4186
75. Weber RG, Sabel M, Reifenberger J et al (1996a) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogens 13 983-994
76. Weber RG, Sommer C, Albert FK, Kiessling M and Cremer T (1996b) Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Laboratory Investigation 74 108-119
77. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81 323-330
78. Weinberg RA (1996) E2F and cell proliferation: a world turned upside down. Cell 85 457-459
79. Winger MJ, Macdonald DR and Cairncross JG (1989) Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. Journal of Neurosurgery 71 487-493
80. Wong AJ, Ruppert JM, Bigner SH et al (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proceedings of the National Academy of Sciences of the USA 89 2965-2969
81. Wu JK and Darras BT (1992) Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas. Neurological Research 14 39-44